Castle Biosciences (CSTL) stock forecast for 2025. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Castle Biosciences (CSTL) stock forecast for 2025

Updated: March 22, 2024 (09:16)

Sector: Healthcare

The share price of Castle Biosciences, Inc. (CSTL) now

What analysts predict: $33.11
52-week High/Low: $26.7 / $9.26

50/200 Day Moving Average: $21.88 / $18.35

This figure corresponds to the Average Price over the previous 50/200 days. For Castle Biosciences stocks, the 50-day moving average is the resistance level today.

For Castle Biosciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Castle Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Castle Biosciences stock price in 2025. How much will one Castle Biosciences share be worth in 2025? Is it worth taking profit / loss on CSTL stock now or waiting? What are analysts' forecasts for Castle Biosciences stock?

We forecast Castle Biosciences stock performance using neural networks based on historical data on CSTL stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Castle Biosciences, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Castle Biosciences analysts is $33.11. Today 200 Day Moving Average is the support level (18.35 $). 50 Day Moving Average is the resistance level (21.88 $).




Historical and forecast chart of Castle Biosciences, Inc. stock

The chart below shows the historical price of Castle Biosciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CSTL stock price can be found in the table below.


Castle of Biological Sciences, Inc., a commercial stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its flagship product is DecisionDx-Melanoma, a Multiple Gene Expression Profile (GEP) test for identifying Stage I and II patients at high risk of metastasis, based on biological information from 31 genes in their tumor tissue. The company also offers the DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis in patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products that address squamous cell skin cancer and suspicious pigmented lesions, which are highly clinical indications for dermatological cancer. It offers testing services through physicians, physician assistants and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.

Castle Biosciences (CSTL) Forecast for 2025

Month Target Pes. Opt. Vol., %
Jan 24.08 21.48 24.75 13.21 %
Feb 23.64 21.72 26.09 16.75 %
Mar 21.75 20.81 22.54 7.70 %
Apr 20.93 19.55 21.90 10.71 %
May 21.55 20.64 22.15 6.81 %
Jun 20.82 18.52 21.81 15.10 %
Jul 23.42 21.81 24.86 12.26 %
Aug 23.61 21.76 24.94 12.73 %
Sep 23.45 21.28 24.99 14.84 %
Oct 22.13 19.81 24.46 19.00 %
Nov 21.05 20.14 21.79 7.57 %
Dec 21.96 19.63 23.87 17.78 %

Castle Biosciences information and performance

Castle Biosciences Address

820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US

Market Capitalization: 558 607 000 $

Market capitalization of the Castle Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CSTL shares in the company outstanding by the market price of one share.

EBITDA: -55 647 000 $

EBITDA of Castle Biosciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.14

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.926
Quarterly Revenue Growth YOY: 0.725
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.51

Enterprise Value (EV) /Revenue

EV To EBITDA: -7.37

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 27450000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Castle Biosciences price target for 2025 by month


Target values for the price of one Castle Biosciences share for Jan 2025.

The weighted average target price per Castle Biosciences share in Jan 2025 is: 24.08.
In Jan, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 13.210% volatility is expected.
Pessimistic target level: 21.48
Optimistic target level: 24.75

Target values for the price of one Castle Biosciences share for Feb 2025.

The weighted average target price per Castle Biosciences share in Feb 2025 is: 23.64.
In Feb, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 16.745% volatility is expected.
Pessimistic target level: 21.72
Optimistic target level: 26.09

Target values for the price of one Castle Biosciences share for Mar 2025.

The weighted average target price per Castle Biosciences share in Mar 2025 is: 21.75.
In Mar, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 7.700% volatility is expected.
Pessimistic target level: 20.81
Optimistic target level: 22.54

Target values for the price of one Castle Biosciences share for Apr 2025.

The weighted average target price per Castle Biosciences share in Apr 2025 is: 20.93.
In Apr, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 10.705% volatility is expected.
Pessimistic target level: 19.55
Optimistic target level: 21.90

Target values for the price of one Castle Biosciences share for May 2025.

The weighted average target price per Castle Biosciences share in May 2025 is: 21.55.
In May, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 6.809% volatility is expected.
Pessimistic target level: 20.64
Optimistic target level: 22.15

Target values for the price of one Castle Biosciences share for Jun 2025.

The weighted average target price per Castle Biosciences share in Jun 2025 is: 20.82.
In Jun, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 15.101% volatility is expected.
Pessimistic target level: 18.52
Optimistic target level: 21.81

Target values for the price of one Castle Biosciences share for Jul 2025.

The weighted average target price per Castle Biosciences share in Jul 2025 is: 23.42.
In Jul, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 12.265% volatility is expected.
Pessimistic target level: 21.81
Optimistic target level: 24.86

Target values for the price of one Castle Biosciences share for Aug 2025.

The weighted average target price per Castle Biosciences share in Aug 2025 is: 23.61.
In Aug, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 12.727% volatility is expected.
Pessimistic target level: 21.76
Optimistic target level: 24.94

Target values for the price of one Castle Biosciences share for Sep 2025.

The weighted average target price per Castle Biosciences share in Sep 2025 is: 23.45.
In Sep, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 14.843% volatility is expected.
Pessimistic target level: 21.28
Optimistic target level: 24.99

Target values for the price of one Castle Biosciences share for Oct 2025.

The weighted average target price per Castle Biosciences share in Oct 2025 is: 22.13.
In Oct, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 19.004% volatility is expected.
Pessimistic target level: 19.81
Optimistic target level: 24.46

Target values for the price of one Castle Biosciences share for Nov 2025.

The weighted average target price per Castle Biosciences share in Nov 2025 is: 21.05.
In Nov, the Negative dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 7.575% volatility is expected.
Pessimistic target level: 20.14
Optimistic target level: 21.79

Target values for the price of one Castle Biosciences share for Dec 2025.

The weighted average target price per Castle Biosciences share in Dec 2025 is: 21.96.
In Dec, the Positive dynamics for Castle Biosciences, Inc. shares will prevail with possible monthly volatility of 17.777% volatility is expected.
Pessimistic target level: 19.63
Optimistic target level: 23.87



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.